SCHEMBL17200970

SCHEMBL17200970

SN1C=C2N=CC=CN2N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23471313 0.73
SCHEMBL9038210 0.69
SCHEMBL1015818 0.61
SCHEMBL4999739 0.54
SCHEMBL17831046 0.53
SCHEMBL23471309 0.52
SCHEMBL23730768 0.51
SCHEMBL762235 0.45
SCHEMBL25964836 0.38
SCHEMBL3464133 0.36

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9657024-B2 Substituted triazolo-pyrimidine compounds for modulating cell proliferation, differentiation and survival STATEGICS, INC. (US) 2017-05-23 US disclosed
US-20150307498-A1 SUBSTITUTED TRIAZOLO-PYRIMIDINE COMPOUNDS FOR MODULATING CELL PROLIFERATION, DIFFERENTIATION AND SURVIVAL THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY 2015-10-29 US disclosed